SavedAdd your journal

Journals / Tıp Araştırmaları Dergisi / 2005 / Cilt: 3 - Sayı: 2

Gastric cancer and HLA

Mide kanseri ve HLA

Mehmet BİLİCİ
Kerim CAYIR
Pages
44–46
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study aimed to investigate the relationship between HLA antigens and gastric cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gastric cancer is an important disease which is seen densely all over the world and which threats public health.
📊
Key Findings & Data:It is seen 3-5 times more frequently in our region than other regions.
💡
Conclusion & Impact:This study aimed to investigate the relationship between HLA antigens and gastric cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:HLA antijenleri · Mide neoplazmları · HLA Antigens

Abstract

Gastric cancer is an important disease which is seen densely all over the world and which threats public health. It is seen 3-5 times more frequently in our region than other regions. The role of genetic polymorphisms in gastric cancer risk has been increasing in the last several years, probably because of advances in DNA analysis technologies and human genome knowledge. This study aimed to investigate the relationship between HLA antigens and gastric cancer.

Özet

Mide tümörleri tüm dünyada sık görülen ve toplum sağlığını tehdit eden önemli bir hastalıktır. Özellikle bölgemizde diğer bölgelere göre 3-5 kat daha fazla sıklıkta görülmektedir. Mide kanseri riskinde genetik polimorfizmin rolü, DNA teknolojisindeki ilerlemeler ve insan genomundaki yeni bilgiler sayesinde özellikle son birkaç yıldır artan bir ilgiye sahip olmuştur. Bu yazıda mide kanseri ile HLA antijenleri arasındaki ilişkileri araştıran çalışmalar gözden geçirilmiştir.

🔖

Cite This Article

BİLİCİ, M., CAYIR, K. (2005). Gastric cancer and HLA. Tıp Araştırmaları Dergisi, Cilt: 3 - Sayı: 2, 44–46. https://ajindex.com/articles/361675

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Wu K, Crusius JBA, Shivanahda S, Fan D, Pena AS. The immunogenetics and pathogenesis of gastric cancer. Drugs of Today 2002; 38: 391-417
  2. Ferlay J, Bray F, Sankila R, Parkin DM. Eucan database. Cancer incidence, mortality and prevalence in the European Union (1996 estimates), version 3.1. European Network of Cancer Registries. Lyon: IARC, 2000
  3. Kanserle Savaş Politikası ve Kanser Verileri 1995- 1999. Ankara: T.C.Sağlık Bakanlığı Kanserle Savaş Dairesi Başkanlığı, 2002: Bakanlık Yayını No: 618
  4. Okçu N. Doğu ve Güneydoğu Anadolu Bölgesinde Mide Kanserinin Demografik Özellikleri. Erzurum: Hepato-Gastroenteroloji Sempozyum Özet Kitapçığı, 2003: 9-12
  5. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int. J. Cancer 2002; 100: 249-260
  6. Azuma T, Ito S, Sato F, Yamakazi Y, Miyaji H, Ito Y, Suto H, Kuriyama M, Kato T, Kohli Y. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by helicobacter pylori infection. Cancer 1998; 82: 1013-1018
  7. Adams D. How the immune system Works and why it causes autoimmune diseases ? Immunology Today 1996; 17: 300-302
  8. Naik S. The human HLA system. J Indian Rheumatol Assoc2003; 11:79-83
  9. Wilson GA, Duff WG. Genetic traits in common disease. BMJ 1995; 310: 1482-1483
  10. Brasanac D, Muller CA, Muller GA, Hadzi Dzokic J, Markovic Lipkovski J: HLA class I antigens expression in renal cell carcinoma: histopatological and clinical correlation. J Exp Clinical Cancer Res 1999; 18: 505-510
  11. Bateman AC, Howell WM. Human leukocyte antigens and cancer: Is it in our genes ? J Pathol 1999; 3: 231-236 12. Buszello H, Ackernann R. Expression of HLA class I antigens on renal cell carcinoma and non-transformed reanl tissue. Eur Urology 1992; 1: 70-74
  12. Perri F, Piepoli A, Quitadamo M, Merla A, Bisceglia M. HLA-DQA1 and -DQB1 genes and Helicobacter pylori infection in Italian patients with gastric adenocarcinoma. Tissue Antigens 2002; 59: 55-57
  13. Ohtani M, Azuma T, Yamakazi S, Yamakawa A, Ito Y, Muramatsu A, Dojo M, Yamakazi Y, Kuriyama M. Association of the HLA-DRB1 gene locus with gastric adenocarcinoma in Japan. Dig Liver Dis 2003; 35: 468- 472
  14. Kodoma Y, Sugimachi K, Soegima K,Matsusaka T, Inokuchi K. Evaluation of intensive lymph node dissection of carcinoma of the stomach. World J Surg 1981; 5: 241-248
  15. Hilton DA, West KP. An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma. Cancer 1990; 66